DRUG
Bright Minds Biosciences
$55.32
+$1.30 (+2.41%)Oct 28, 2026
Key metrics
The numbers that frame DRUG today
- Market cap
- $542.80M
- ROIC
- 5,671.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $47.23
- 52wk High
- $123.75
Growth
Revenue and earnings trend for DRUG
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DRUG
Is Bright Minds Biosciences a good buy?
No. Bright Minds Biosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Bright Minds Biosciences is selling at a high price.
What is the market capitalization of DRUG?
Bright Minds Biosciences's market capitalization is $542.80M.
What is the 52-week high for DRUG stock?
The 52-week high for Bright Minds Biosciences is $123.75. The current close of $55.32 is 55.3% below that high.
What is the 52-week low for DRUG stock?
The 52-week low for Bright Minds Biosciences is $47.23. The current close of $55.32 is 17.1% above that low.
Does DRUG stock pay dividends?
Bright Minds Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DRUG?
Bright Minds Biosciences's Debt / Equity ratio is 0.